Agreed Dave.
Although for me the clip was poorly produced, edited and delivered by sevens journalist, from an Imugene perspective the points noted were clear.
Those being:
1. LC states that pre clinically CF33 killed all cancers against the NC1 60, that's right, all cancers
2. We, as viewers can visually see the virus working, stimulating the immune system, killing cancer cells and leaving healthy cells alone (see exert from the news clip in green), and
3. YF is precise in his statement that CF33 in clinical trials has arrested (slowed) cancer, killed some tumours and in instances eradicated all solid tumours in cancer patients.
We know the parental and potent dose of CF33, that being Vaxinia, has only recently been dose escalated to 10 parts to the 8, a dosage level from which YF anticipates good results shall ensue. Whether or not viewers of the 7 news story put 1 and 3 together and realise the story is all about Imugene and whether or not the bile duct interviewee is in fact now or soon to be a Vaxinia patient, or whether or not the Cholangiocarcinoma Foundation is indeed working to recruit patients to the bile duct cohort in the current Vaxinia Trial, may in the long run prove irrelevant. For if some of those dosed with Vaxinia in January do result in complete tumour eradication, it's game, set and match for Imugene. The drug won't need promotion, recruitment nor news stories to convey the message. The results shall sell themselves, to patients and public alike.
For those following Imugene closely the story hasn't changed. LC and YF have been singing from the same hymn sheet for years now. CF33/Vaxinia works. It eradicates solid tumours. Its simply taking some people a little longer to get their heads around it. Its obviously taking some people a little longer to comprehend, understand and believe in the science. Hence the relatively low IMU share price.
DYOR Seek investment advice as and when required Opinions only
P.S IMO This isn't a dream, an opportunity or a possibility. IMO it's a reality. Vaxinia is currently working in patients to eradicate solid tumours.
The sooner the better people reach this conclusion, (i.e., as the FDA has,) the sooner Imugene shall achieve the necessary impetus required to take it to the next level...
Expand
(20min delay)